Header Logo

Connection

KEVIN ERICKSON to United States

Back to Details
This is a "connection" page, showing publications KEVIN ERICKSON has written about United States.
KEVIN ERICKSON
Connection Strength
2.074
United States
  1. Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
    View in: PubMed
    Score: 0.076
  2. Facility Closures and Distance Traveled to Receive Dialysis Care in the United States. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1610-1612.
    View in: PubMed
    Score: 0.076
  3. Considering the Effects of a Recent US Supreme Court's Ruling on Dialysis Care Costs. Clin Ther. 2023 03; 45(3):272-276.
    View in: PubMed
    Score: 0.074
  4. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.073
  5. The US Supreme Court and Future of Financing Dialysis Care. Clin J Am Soc Nephrol. 2023 02 01; 18(2):273-275.
    View in: PubMed
    Score: 0.073
  6. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.071
  7. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.069
  8. The beneficial effect of providing kidney transplantation information on transplantation status differs between for-profit and nonprofit dialysis centers. Transpl Int. 2021 12; 34(12):2644-2668.
    View in: PubMed
    Score: 0.068
  9. How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets? JAMA Health Forum. 2021 11 02; 2(11):e213378.
    View in: PubMed
    Score: 0.067
  10. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.067
  11. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.066
  12. ACOs and Bending the Cost Curve for Health Care Spending for People with Kidney Failure. Clin J Am Soc Nephrol. 2020 12 07; 15(12):1699-1701.
    View in: PubMed
    Score: 0.063
  13. Payer Mix Among Patients Receiving Dialysis. JAMA. 2020 09 01; 324(9):900-901.
    View in: PubMed
    Score: 0.062
  14. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.060
  15. Physician reimbursement for outpatient dialysis care: Past, present, and future. Semin Dial. 2020 01; 33(1):68-74.
    View in: PubMed
    Score: 0.059
  16. Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020 01; 33(1):90-99.
    View in: PubMed
    Score: 0.059
  17. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.059
  18. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.059
  19. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
    View in: PubMed
    Score: 0.057
  20. Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States. Clin J Am Soc Nephrol. 2019 08 07; 14(8):1200-1212.
    View in: PubMed
    Score: 0.057
  21. Nephrology Advanced Practitioners in the United States, 2010-2018. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1381-1382.
    View in: PubMed
    Score: 0.057
  22. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.055
  23. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.055
  24. Making Policy in the Dark: The Use of Activated Vitamin D Under Bundled Payments for Dialysis?Care. Am J Kidney Dis. 2018 08; 72(2):161-163.
    View in: PubMed
    Score: 0.054
  25. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.054
  26. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.053
  27. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.051
  28. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.046
  29. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.042
  30. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.040
  31. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
    View in: PubMed
    Score: 0.037
  32. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.037
  33. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81.
    View in: PubMed
    Score: 0.036
  34. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
    View in: PubMed
    Score: 0.021
  35. Optimal Care for Kidney Health: Development of a Merit-based Incentive Payment System (MIPS) Value Pathway. J Am Soc Nephrol. 2023 08 01; 34(8):1315-1328.
    View in: PubMed
    Score: 0.019
  36. Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. J Am Soc Nephrol. 2020 03; 31(3):602-614.
    View in: PubMed
    Score: 0.015
  37. Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698.
    View in: PubMed
    Score: 0.015
  38. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.014
  39. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.014
  40. Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703.
    View in: PubMed
    Score: 0.013
  41. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.013
  42. Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar; 106(3):406-7.
    View in: PubMed
    Score: 0.011
  43. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.